Takahiro Yoshioka

Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in <i>EGFR</i> -Mutant Non–Small Cell Lung Cancer Cells

Kei Namba, Kazuhiko Shien, Yuta Takahashi et al. · Molecular Cancer Research · 2018 · 93 citations · Full text

Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer

Hiroki Sato, Hiromasa Yamamoto, Masakiyo Sakaguchi et al. · Cancer Science · 2018 · 65 citations · Full text

Nitrogen solubility in the deep mantle and the origin of Earth's primordial nitrogen budget

Takahiro Yoshioka, Michael Wiedenbeck, Svyatoslav Shcheka et al. · Earth and Planetary Science Letters · 2018 · 61 citations

Biogeochemistry, Engineering, Geology +7

Antitumor activity of pan‐<scp>HER</scp> inhibitors in <scp>HER</scp>2‐positive gastric cancer

Takahiro Yoshioka, Kazuhiko Shien, Kei Namba et al. · Cancer Science · 2018 · 42 citations · Full text

Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

Tatsuaki Takeda, Hiromasa Yamamoto, Hirotaka Kanzaki et al. · PLoS ONE · 2017 · 41 citations · Full text